≡ Risteys R6

Methods Changelog GitHub Contact & Feedback

Use of etanautine orphenadrine

PheWeb

No definition available.

Endpoint definition

↥
FinnGen phenotype data
diagram bullet diagram downward connector

Filter registries KELA purch., KELA reimb.

Medicine purchases: ATC N04AB
Medicine purchases: ATC: other data required >3 instances required

Check pre-conditions None

Include endpoints None

Check conditions None

Apply sex-specific rule None

diagram downward connector PDMED_ETANAUTINE_ORPHENADRINE

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to Use of etanautine orphenadrine based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

None

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

All Female Male
Number of individuals - - -
Unadjusted prevalence (%) - - -
Mean age at first event (years) - - -

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Correlations

↥

Index endpoint: PDMED_ETANAUTINE_ORPHENADRINE – Use of etanautine orphenadrine
GWS hits:

Survival analyses between endpoints

↥

Plot

before Use of etanautine orphenadrine
after Use of etanautine orphenadrine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Use of etanautine orphenadrine

↥